can doctors work with pbm for glp-1 approval Medications: Expert Guide Employers and Plan Sponsors Glucagon-like peptide-1 (GLP-1) injectable medications

Taking a GLP-1 may lead to low potassium if you are eating fewer potassium-rich foods because of a reduced appetite, exercising more (and therefore sweating more), or if youre experiencing medication side effects, such as vomiting or diarrhea

Expanding real-world data collection and employing advanced translational models will be important for evaluating the applicability and safety of SIRT1-based interventions across diverse metabolic phenotypes

doi: 10.1016/j.bjps.2023.04.057 Humphrey CD and Lawrence AC

Whether evaluating GLP-1 peptides, dual incretin agonists, triple receptor agonists, or hormonal axis peptides, the underlying principle remains pathway precision